Bioorganic and Medicinal Chemistry Letters p. 1311 - 1316 (1999)
Update date:2022-08-05
Topics:
Williams, Peter D.
Bock, Mark G.
Evans, Ben E.
Freidinger, Roger M.
Gallicchio, Steven N.
Guidotti, Maribeth T.
Jacobson, Marlene A.
Michelle S, Kuo
Levy, Michelle R.
Edward V, Lis
Michelson, Stuart R.
Pawluczyk, Joseph M.
Perlow, Debra S.
Pettibone, Douglas J.
Quigley, Amy G.
Reiss, Duane R.
Salvatore, Christopher
Stauffer, Kenneth J.
Woyden, Carla J.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257; K(i) = 9.3 nM) have led to the identification of a related series of compounds containing an ortho-trifluoroethoxyphenylacetyl core which are orally bioavailable and have significantly improved potency in vitro and in vivo, e.g., compound 8 (L-374,943; K(i) = 1.4 nM).
View MoreValiant Fine Chemicals Co., Ltd.
Contact:+86 535 6101878/6374484
Address:11 Wuzhishan Rd.,YTETDZ,Yantai,264006,Shandong,China
Shanghai Massive Chemical Technology Co., Ltd.
website:http://www.massivechem.com/
Contact:+86 21 34943721
Address:Room 435, 4th floor, Building 9, No. 2568 Gudai Road,Minhang District, Shanghai,
JinTan Pingsheng Chemical Co.,Ltd
Contact:+86-519-82828200
Address:NO.11Danfengxilu Road,Jintan City,Jiangsu,China
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
Contact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Doi:10.1021/ja00271a033
(1986)Doi:10.1002/cjoc.201090280
(2010)Doi:10.1055/s-0035-1562528
(2016)Doi:10.1007/BF00869027
()Doi:10.1021/jo00966a004
(1972)Doi:10.1007/BF00849353
()
